DeepMed Research

Yuhan Corporation

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Bioequivalence Study Between YHP2205 and YHR2401 in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: YHP2205
Drug: YHR2401

First Posted Date: 2024-04-11

Last Posted Date: 2024-11-12

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 60

Registration Number: NCT06359626

Locations: 🇰🇷
Bumin Hospital, Seoul, Korea, Republic of

Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia

Completed

Conditions: Hypertension
Hypercholesterolemia

Interventions: Drug: Rosuampin 5/5mg, 10/5mg, 20/5mg, 10/10mg

First Posted Date: 2024-03-05

Last Posted Date: 2025-01-22

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 5047

Registration Number: NCT06293261

Locations: 🇰🇷
Dong-A University Hospital, Busan, Korea, Republic of
🇰🇷
Gyeongsang National University Changwon Hospital, Changwon, Korea, Republic of
🇰🇷
Daegu Catholic University Medical Center, Daegu, Korea, Republic of

and more 36 locations

Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension

Active, not recruiting

Conditions: Essential Hypertension

First Posted Date: 2024-02-28

Last Posted Date: 2024-11-19

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 1219

Registration Number: NCT06282549

Locations: 🇰🇷
Busan Veterans Hospital, Busan, Korea, Republic of
🇰🇷
Daegu Veterans Hospital, Daegu, Korea, Republic of
🇰🇷
Gwangju Veterans Hospital, Gwangju, Korea, Republic of

and more 2 locations

Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation

Active, not recruiting

Conditions: NSCLC

First Posted Date: 2024-02-07

Last Posted Date: 2024-12-06

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 2001

Registration Number: NCT06247280

Locations: 🇰🇷
Kyungpook National University Chilgok Hospital, Chilgok, Daegu, Korea, Republic of
🇰🇷
Wonju Severance Christian Hospital, Wonju, Gangwon-do, Korea, Republic of
🇰🇷
Hallym Univ. Medical Center. Chuncheon, Chuncheon, Gangwon, Korea, Republic of

and more 36 locations

Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease

Phase 4

Completed

Conditions: Arterial Occlusive Diseases
Intermittent Claudication

Interventions: Drug: Sarpogrelate SR
Drug: Sarpogrelate

First Posted Date: 2023-09-21

Last Posted Date: 2023-09-21

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 148

Registration Number: NCT06046196

Locations: 🇰🇷
GangNeung Asan Hospital, Gangneung-si, Gangwon-do, Korea, Republic of
🇰🇷
Inje University Ilsan Paik Hospital, Goyang-si, Gyeonggi-do, Korea, Republic of
🇰🇷
Dong-A University Hospital, Busan, Korea, Republic of

and more 4 locations

Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension

Phase 4

Recruiting

Conditions: Essential Hypertension

Interventions: Drug: Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg
Drug: Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mg

First Posted Date: 2023-09-18

Last Posted Date: 2024-11-18

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 250

Registration Number: NCT06041529

Locations: 🇰🇷
Pusan National University Yangsan Hospital, Busan, Korea, Republic of
🇰🇷
Wonju Severance Christian Hospital, Gangwon-do, Korea, Republic of
🇰🇷
Gwangju Veterans Hospital, Gwangju, Korea, Republic of

and more 12 locations

A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases

Phase 1

Completed

Conditions: Chronic Spontaneous Urticaria
Chronic Inducible Urticaria
Cold Urticaria
Allergic Disease

Interventions: Drug: YH35324
Drug: Omalizumab
Drug: Placebo

First Posted Date: 2023-07-27

Last Posted Date: 2024-11-22

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 36

Registration Number: NCT05960708

Locations: 🇰🇷
Hallym University Sacred Heart Hospital, Anyang-si, Gyeonggi-do, Korea, Republic of
🇰🇷
Hallym University Dongtan Sacred Heart Hospital, Hwaseong-si, Gyeonggi-do, Korea, Republic of
🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

and more 6 locations

Retrospective, External Comparator Study of Lazertinib as the 2nd-Line Treatment in Patients With EGFR Mutation+ NSCLC

Completed

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: Platinum-based Chemotherapy
Drug: Lazertinib

First Posted Date: 2023-05-17

Last Posted Date: 2023-08-22

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 534

Registration Number: NCT05862194

An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS

Recruiting

Conditions: Ankylosing Spondylitis
Rheumatoid Arthritis

First Posted Date: 2023-04-28

Last Posted Date: 2023-05-09

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 1000

Registration Number: NCT05835518

Locations: 🇰🇷
Daegu Catholic University Medical Center, Daegu, Korea, Republic of

A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease

Phase 4

Completed

Conditions: Sarpogrelate
Blood Viscosity
Coronary Artery Disease
Peripheral Arterial Disease

Interventions: Drug: Sarpogrelate Sustained Release/Aspirin
Drug: Aspirin

First Posted Date: 2023-02-16

Last Posted Date: 2025-01-22

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 68

Registration Number: NCT05730621

Locations: 🇰🇷
The Catholic University of Korea Uijeongbu St. Mary's Hospital, Uijeongbu, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy